Travere Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,037 | 0.0% | 79,472 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,910 | 0.0% | 79,936 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,068 | 0.0% | 72,192 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,294 | 0.0% | 72,192 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,258 | 0.0% | 72,192 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 911 | 0.0% | 65,151 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 554 | 0.0% | 67,366 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 577 | 0.0% | 74,883 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 709 | 0.0% | 78,813 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 674 | 0.0% | 75,424 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 1,229 | 0.0% | 79,988 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 1,803 | 0.0% | 80,175 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 1,512 | 0.0% | 71,911 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,737 | 0.0% | 70,504 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,740 | 0.0% | 71,802 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,864 | 0.0% | 72,330 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 2,434 | 0.0% | 78,416 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,844 | 0.0% | 76,030 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,173 | 0.0% | 80,425 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 2,084 | 0.0% | 83,458 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 2,018 | 0.0% | 74,039 | 12/31/2020 |